Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
37
ALFFF Quote, Financials, Valuation and Earnings
Last price:
$0.88
Seasonality move
:
51.1%
Day range:
$0.88 - $0.88
52-week range:
$0.41 - $0.88
Dividend yield:
2.43%
P/E ratio:
--
P/S ratio:
0.54x
P/B ratio:
5.99x
Volume:
--
Avg. volume:
378
1-year change:
12.77%
Market cap:
$4.9B
Revenue:
$8.9B
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Sigma Foods SAB de CV has -- downside to fair value with a price target of -- per share.
ALFFF vs. S&P 500
-
Over the past 5 trading days, Sigma Foods SAB de CV has overperformed the S&P 500 by 1.23% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Sigma Foods SAB de CV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sigma Foods SAB de CV has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Sigma Foods SAB de CV reported revenues of $2.4B.
Earnings Growth
-
Sigma Foods SAB de CV has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Sigma Foods SAB de CV reported earnings per share of $0.01.
Enterprise value:
7.6B
EV / Invested capital:
--
Price / LTM sales:
0.54x
EV / EBIT:
12.35x
EV / Revenue:
0.84x
PEG ratio (5yr expected):
--
EV / Free cash flow:
6.69x
Price / Operating cash flow:
4.29x
Enterprise value / EBITDA:
8.83x
Gross Profit (TTM):
$2.7B
Return On Assets:
0.12%
Net Income Margin (TTM):
0.13%
Return On Equity:
0.82%
Return On Invested Capital:
0.26%
Operating Margin:
7.46%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $15B | $8.9B | $9B | $2.2B | $2.4B | |
| Gross Profit | $2.9B | $2.8B | $2.7B | $714.9M | $718.4M | |
| Operating Income | $865.7M | $743.3M | $613.3M | $207.4M | $180.8M | |
| EBITDA | $1.3B | $1.1B | $857.7M | $267.1M | $244.7M | |
| Diluted EPS | $0.04 | -$0.11 | -$0.01 | -$0.00 | $0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.5B | $7.6B | $5.6B | $9B | $2.7B | |
| Total Assets | $13.1B | $14.7B | $13.1B | $12.9B | $6.7B | |
| Current Liabilities | $3.5B | $5.6B | $4.5B | $6.3B | $2.2B | |
| Total Liabilities | $10.2B | $11.7B | $10.4B | $10.3B | $5.8B | |
| Total Equity | $2.9B | $3B | $2.6B | $2.6B | $823.1M | |
| Total Debt | $6B | $5.6B | $6B | $3.7B | $3.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.4B | $270.2M | $1.5B | -$394.5M | $117.5M | |
| Cash From Investing | -$845.2M | -$209.8M | -$599.6M | $11.2M | -$97.2M | |
| Cash From Financing | -$656.4M | -$425.1M | -$1.1B | $27.7M | -$41.4M | |
| Free Cash Flow | $1B | $141.5M | $1.1B | -$393.9M | $15.8M | |
ALFFF
Sector
Market Cap
$4.9B
$119.3M
Price % of 52-Week High
100%
71.06%
Dividend Yield
2.43%
0%
Shareholder Yield
14.71%
2.3%
1-Year Price Total Return
12.77%
-6.57%
Beta (5-Year)
0.700
0.255
Dividend yield:
2.43%
Annualized payout:
$0.01
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.88
200-day SMA
Buy
Level
$0.76
Bollinger Bands (100)
Buy
Level
0.75 - 0.83
Chaikin Money Flow
Sell
Level
-946.8K
20-day SMA
Buy
Level
$0.86
Relative Strength Index (RSI14)
Buy
Level
93.60
ADX Line
Buy
Level
75
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$0.81
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
17.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5008)
Sell
CA Score
(Annual)
Level (-1.7714)
Buy
Beneish M-Score
(Annual)
Level (-3.758)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (2.4922)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sigma Foods SAB de CV is a holding company, which produces, markets, and distributes food through recognized brands in Mexico, the United States, Europe, and Latin America. It operates through the following segments: Alpek, Sigma, and Others. The Alpek segment operates in the petrochemical and synthetic fibers industry, and its revenues are derived from sales of its primary products: polyester, plastics, and chemicals. The Sigma segment engages in the refrigerated food sector and its revenues are derived from sales of its main products: deli meats, dairy, and other processed foods. The Other segments includes all other companies operating in business services and others, which are non-reportable segments. The company was founded by Roberto Garza Sada on June 9, 1974 and is headquartered in San Pedro Garza García, Mexico.
Stock Forecast FAQ
In the current month, ALFFF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALFFF average analyst price target in the past 3 months is --.
-
Where Will Sigma Foods SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sigma Foods SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sigma Foods SAB de CV?
Analysts are divided on their view about Sigma Foods SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sigma Foods SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Sigma Foods SAB de CV's Price Target?
The price target for Sigma Foods SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ALFFF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sigma Foods SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ALFFF?
You can purchase shares of Sigma Foods SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sigma Foods SAB de CV shares.
-
What Is The Sigma Foods SAB de CV Share Price Today?
Sigma Foods SAB de CV was last trading at $0.88 per share. This represents the most recent stock quote for Sigma Foods SAB de CV. Yesterday, Sigma Foods SAB de CV closed at $0.88 per share.
-
How To Buy Sigma Foods SAB de CV Stock Online?
In order to purchase Sigma Foods SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ALFFF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALFFF
Sector
P/E ratio
--
16.72x
PEG ratio
--
0.13x
P/B ratio
5.99x
1.49x
Price / LTM sales
0.54x
0.52x
Growth Metrics
ALFFF
Sector
Revenue growth
7.8%
2.99%
Earnings growth
2350%
3.56%
Revenue (5-year growth)
-8.02%
3.32%
Earnings forecast
--
$0.28
Profitability
ALFFF
Sector
Profitability FY 2024
$2.7B
$263.1M
Return on invested capital
0.26%
4.37%
Return on assets
0.12%
3.04%
Return on equity
0.82%
7.48%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Feb
18
Estimated Next Earnings Date
Jan
21
Balance Sheet
ALFFF
Sector
Total cash
$553.6M
$85.8M
Short term investments
--
$31.1M
Total assets
$11.4B
$1.1B
Long term debt
$3.2B
$6.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 6.15% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.84% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 10.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
